AparnaBio is developing a portfolio of biomedical nanoparticles based on our versatile branched polymer conjugates that enable NanoElectroPlex™ technology to be tuned for specific applications, including tissue Targeting. This uniquely powerful capability has been incorporated into AparnaBio’s InVivoPlex™ research reagents for in vivo delivery of siRNA and is being developed for therapeutics and imaging. In addition, some NanoElectroPlex™ polymers are attractive for Anti-fungal therapeutics, exhibiting fungicidal activity against Candida, Aspergillus and Cryptococus species responsible for life threatening invasive fungal infections.